Screening for colorectal cancer, 1996

Medical Journal of Australia

Volumn 165, Issue 2, 1996, Pages 102-105

  Macrae, Finlay A ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AUSTRALIA; CANCER SCREENING; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; HIGH RISK POPULATION; HUMAN; OCCULT BLOOD; PATIENT COMPLIANCE; PUBLIC HEALTH; SHORT SURVEY; SIGMOIDOSCOPY;

EID: 0029780259     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1996.tb124860.x     Document Type: Short Survey

References (42)

1. Coates M, McCredie M, Armstrong B. New South Wales Central Cancer Registry, Cancer in New South Wales, Annual reports 1973-1990. Incidence and mortality. Sydney: NSW Cancer Council, 1991.
2. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993; 328: 1365-1371.
3. Winawer SJ, Flehringer BJ, Schottenfeld D, Miller DG. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst 1993; 85: 1311-1318.
4. Hardcastle JD, Thomas WM, Chamberlain J, et al. Randomised controlled trial of faecal occult blood screening for colorectal cancer: results of first 107 349 subjects. Lancet 1989; 1: 1160-1164.
5. Kronborg O, Fenger C, Olsen J, et al. Repeated screening for colorectal cancer with faecal occult blood test: a prospective randomized study at Funen, Denmark. Scand J Gastroenterol 1989; 24: 599-606.
6. Kewenter J, Bjork S, Haglind E, et al. Screening and re-screening for colorectal cancer. A controlled trial of fecal occult blood tasting in 27700 subjects. Cancer 1988; 62: 645-651.
7. Gill TM, Horwitz RI. Evaluating the efficacy of cancer screening: clinical distinctions and case-control studies, J Clin Epidemiol 1995; 48: 281-292.
8. Ee HC, Young JP. DNA repair and inherited cancer. J Gastroenterol Hepatol 1995; 10: 108-109.
9. Newell D. Intention-to-treat analysis: implications for quantitative and qualitative research. Int J Epidemiol 1992; 21: 837-841.
10. Lang CA, Ransohoff D. Fecal occult blood screening for colorectal cancer. JAMA 1994; 271: 1011-1013.
11. Selby JV, Friedman GD, Quesenberry CP, Weiss NS. Effect of fecal occult blood testing on mortality from colorectal cancer. A case-control study. Ann Intern Med 1993; 118: 1-6.
12. Wahrendorf J, Robra B-P, Wiebelt H, et al. Effectiveness of colorectal cancer screening: results from a population-based case-control evaluation in Saarland, Germany. Eur J Cancer Prev 1993; 2: 221-227.
13. Saito H, Soma Y, Koeda J, et al. Reduclion in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test. A case-control study. Int J Cancer 1995; 61: 465-469.
14. Willett W, Stampfer MJ, Colditz GA, et al. Relation of meat, fat and fiber intake to the risk of colon cancer in a prospective study in women. N Engl J Med 1990; 323: 1664-1672.
15. Phillips RL, Snowdon DA. Dietary relationships with fatal colorectal cancer among Seventh-day Adventists. J Natl Cancer Inst 1985; 74: 307-317.
16. St John DJB, Young GP, Alexeyeff MA, et al. Evaluation of new occult blood tests for detection of colorectal neoplasia. Gastroenterology 1993; 104: 1661-1668.
17. Macrae FA, St John DJB. Relationship between patterns of bleeding and Hemoccull sensitivity in patients with colorectal cancers or adenomas. Gastroenterology 1982; 82: 891-898.
18. Selby JV, Friedman GD, Quesenberry CP, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992; 326: 653-657.
19. Newcomb PA, Norfleet RG, Stoner BE, et al. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992; 84: 1572-1575.
20. Atkin WA, Cuzick J, Northover JMA, Whynes DK. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet 1993; 341: 736-740.
21. Rex DK, Lehman GA, Hawes RH, et al. Screening colonoscopy in asymptomatic average risk persons with negative fecal occult blood tests. Gastroenterology 1991; 100: 64-67.
22. Macrae FA, Hill I, St John DJB Predicting colon cancer screening behaviour from health beliefs. Prev Med 1984; 13: 115-126.
23. Frommer DJ, Kappario A. Brown MK. Improved screening for colorectal cancer by immunochemical detection of occult blood. BMJ 1988; 296: 1092-1094.
24. Australian Gastroenterology Institute/Australian Cancer Society. Guidelines for early detection screening and surveillance for colorectal cancer, 2nd ed. Sydney: Australian Gastroenterology Institute/Australian Cancer Society, 1994.
25. St John DJB, McDermott FT, Hopper JL, et al. Cancer risk in relatives of patients with common colorectal cancer. Ann Intern Med 1993; 188: 785-790.
26. Lovett E. Family studies in cancer of the colon and rectum. Br J Surg 1976; 63: 13-18.
27. Maire P, Morichau-Beauchant M, Drucker J, et al. Prévalence familiale du cancer du côlon, et du rectum: résultats d'une enquête "cas-témoins" de 3 ans. Gastroenterol Clin Biol 1984; 8: 22-27.
28. Winawer SJ, et al. Risk of cancer in relatives of patients with adenomas. N Engl J Med. In press.
29. Lynch HT, Smyrk TC, Watson P, et al. Genetics, natural history, tumour spectrum and pathology of hereditary non-polyposis colorectal cancer: an updated review. Gastroenterology 1993; 104: 1535-1549.
30. Macrae FA. Bowel cancer: watching over the family. J Gastroenterol Hepatol 1995; 10: 337-338.
31. Kohonen-Cornish M, St John DJB, Macrae FA, et al. Genetic defects in hereditary non-polyposis colon cancer. J Hepatol Gastroenterol 1995; 10: A38.
32. Nagase H, Miyosh Y, Horii A, et al. Correlation between the location of germ-line mutations in the APC gene and the number of colorectal polyps in familial adenomatous polyposis patients. Cancer Res 1992; 52: 4055-4057.
33. Grossman S, Milos ML, Tewaka IS, Jewell NP. Colonoscopic screening of persons with suspected risk factors for colon cancer. II. Past history of colorectal neoplasms. Gastroenterology 1989; 96: 299-306.
34. Williams CB, Macrae FA. The St Mark's neoplastic polyp follow-up study. In: Rozen P, Winawer SJ, editors. Secondary prevention of colorectal cancer: An international perspective. Basel: Karger, 1986: 226-242.
35. Atkin WS, Morsm BC, Cuzick J, Long-term risk of colorectal cancer alter excision of rectosigmoid adenomas. N Engl J Med 1992; 326 658-662.
36. Bjlow S, Svendsen LB, Mellemgaard A. Metachronous colorectal cancer. Br J Surg 1990; 77: 502-505.
37. Winawer SJ, Zauber AG, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993; 329: 1977-1981.
38. Murakami R, Tsukuma H, Kanamori S, et al. Natural history of colorectal polyps and the effect of polypectomy on occurrence of subsequent cancer. Int J Cancer 1990; 46: 159-164.
39. Winawer SI, Zauber AG, O'Brien MJ, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. N Engl J Med 1993; 328: 901-906.
40. Lennard Jones JE, Melville DM, Morson BC, et al. Precancer and cancer In extensive ulcerative colitis: findings among 401 patients over 22 years. Gut 1990; 31: 800-806.
41. US Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore: Williams & Wilkins, 1996: 89-103.
42. Solomon MJ, McLeod RS and the Canadian Task Force on the Periodic Health Examination. Periodic health examination. 1994 update: 2. Screening strategies for colorectal cancer. Can Med Assoc J 1994; 150: 1961-1970.